The role of imaging in clinical trials is increasingly important. Imaging offers a non-invasive assessment of drug action and tumor response to treatment, allowing the disease monitoring to be performed continuously without causing any discomfort to the patient. As the role of imaging in clinical trials has grown, local interpretation of imaging findings is no longer sufficient due to the potential for bias and unpredictability in image interpretation. iKoreLab's experienced team of Radiologists provide standardized unprejudiced imaging results from phases 1 to 4 in Clinical trials.
Contact us